Berkeley, CA, United States of America

Michael James Cope

This inventor holds 26 USPTO granted patents and 9 published patent applications, plus 9 CIPO patents and 16 EPO patents, primarily in Ion Binding Polymers. Top assignees: Relypsa, Inc., Tricida, Inc., Ilypsa, Inc.. Active years: 2009-2024.

USPTO Granted Patents = 26 

% Patents Active = 80.8


 

Average Co-Inventor Count = 10.7

ph-index = 9

Forward Citations = 205(Granted Patents)


Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Ion Binding Polymers
Acid-Base Disorders
Potassium Ion Removal
Pharmaceutical Compositions
Bile Acid Sequestrants
Proton-Binding Polymers
Hyperphosphatemia Treatment
Anion-Binding Polymers
Crosslinked Polymers
Multivalent Indole Compounds
Ion Imbalances
Small Molecule Amine Polymers
26 patents (USPTO):Explore Patents

Title: Michael James Cope: Innovator in Pharmaceutical Compositions

Introduction

Michael James Cope, based in Berkeley, California, is an accomplished inventor with a remarkable portfolio of 26 patents. His work primarily focuses on advancements in the field of pharmaceutical compositions, especially in treating acid-base disorders in animals, including humans.

Latest Patents

Among his latest contributions, Mr. Cope has developed innovative pharmaceutical compositions aimed at addressing metabolic conditions. One of his recent patents includes compositions for and methods of treating acid-base disorders. This invention involves nonabsorbable compositions that help treat diseases by normalizing serum bicarbonate concentrations and blood pH levels.

Another significant patent from his portfolio involves proton-binding polymers for oral administration. These crosslinked amine polymers are designed to remove protons and chloride ions from the gastrointestinal tract, offering physiological benefits similar to his earlier work on acid-base disorders.

Career Highlights

Throughout his career, Michael James Cope has made significant strides in pharmaceutical innovation, particularly in working on practical solutions that address pressing health issues. His experience at companies such as Relypsa, Inc. and Tricida, Inc. has greatly enhanced his expertise in drug development and patenting.

Collaborations

Collaboration has played a crucial role in Mr. Cope's innovative journey. He has worked closely with notable colleagues, including Eric F. Connor and Jerry M. Buysse, contributing to the advancement of the pharmaceutical field through teamwork and shared knowledge.

Conclusion

Michael James Cope stands out as a noteworthy inventor in the realm of pharmaceutical innovations. His dedication to developing compositions that benefit health demonstrates the impactful role innovators play in improving medical treatments and patient care. With continuous contributions to the field, his work will likely influence future advancements in pharmaceutical sciences.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…